Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × Immune Checkpoint Inhibitors × Clear all

NCT04229355 2021-02-09

DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular